Elicio Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Elicio Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Elicio Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.93M, a 12.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.93M -$842K -12.4% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $6.14M -$810K -11.7% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $6.35M +$6.23M +4943% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $6.56M -$787K -10.7% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $6.77M +$3.39M +100% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $6.95M +$3.36M +93.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $126K -$3.66M -96.7% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $7.35M +$3.36M +84.4% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $3.38M -$794K -19% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.59M -$775K -17.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $3.79M -$751K -16.5% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $3.99M -$86K -2.11% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $4.18M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $4.36M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $4.54M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $4.07M Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.